Media contacts

Latest news releases

View all releases

Vaccines deliver over US$ 30 billion in economic benefits for lower-income countries in 2025

Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs and healthier, more productive populations.

Made in Africa: New measles rapid diagnostic tests mark breakthrough for vaccination efforts

First-of-their-kind rapid measles diagnostic tests will support targeted vaccination during outbreaks and identification of priorities for preventive vaccination efforts.

Media resources | assets

If you are a journalist, you can sign up to receive our media alerts, press releases and announcements.

Subscribe

If you would you like to request access to our digital library of high-resolution images and B-roll, please email media@gavi.org.

Gavi leadership

Opinions

View all opinions

The Ebola situation is grave; we must use every tool we have to save lives

We must deploy every tool at our disposal to bring the Bundibugyo Ebola outbreak to an end. The existing Ebola Zaire vaccine, for which Gavi funds a global stockpile, could help save lives and reduce the suffering.

Ebola shows us the importance of resilience as much as response

Repeated outbreaks in the DRC expose the world’s failure to build resilient health systems, underscoring the urgent need for coordinated, sustainable global health reform.

Collaboration will be key in race for vaccine to control rare Ebola strain

Gavi and CEPI issue an urgent plan for the response to the latest Ebola outbreak, caused by the Bundibugyo virus.

Last updated: 9 Oct 2026